SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

Nov 24, 2017

2. SEC Identification Number

39652

3. BIR Tax Identification No.

004-844-938

4. Exact name of issuer as specified in its charter

Medco Holdings, Inc.

5. Province, country or other jurisdiction of incorporation

Philippines

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

31/F, Rufino Pacific Tower, 6784 Ayala Ave., Makati City, Metro Manila, Philippines Postal Code 1229

8. Issuer's telephone number, including area code

(632) 811-0465 to 66

9. Former name or former address, if changed since last report

N/A

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common	700,000,000

11. Indicate the item numbers reported herein

Other Events

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

MEDCO Holdings, Inc.MED

PSE Disclosure Form QR-1 - Quasi-Reorganization References: Rules on Quasi-Reorganization
SRC Rule 17 (SEC Form 17-C)

Subject of the Disclosure
Equity Restructuring
Background/Description of the Disclosure
The Board, in their Special Meeting on 31 May 2017, approved the decrease in the Corporation's authorized capital stock from Php700 million divided into 700 million common shares to Php35 million divided into 700 million common shares by reducing par value per share from Php1.00 to Php0.05 in order to reduce the Corporation's deficit. Once the equity restructuring has been approved and completed, the Company shall then increase its Authorized Capital Stock from Php35 million divided into 700 million shares with par value of Php0.05 per share to Php470 million divided into 9.4 billion common shares with par value of Php0.05 per share.

Date of Approval by Board of Directors	May 31, 2017
Date of Approval by Stockholders	Nov 24, 2017
Date of Approval by Securities and Exchange Commission	TBA

Rationale for quasi-reorganization
To reduce the Corporation's deficit.

Amount of deficit that will be eliminated	Php690,498,912

Adjustment(s) on the following

Authorized Capital Stock (ACS)

Type of Security / Stock Symbol	Before Capital Restructuring (current)	Decrease in ACS	Increase in ACS	After Capital Restructuring
Common stock/MED	Php700,000,000.00	Php665,000,000.00	Php435,000,000.00	Php470,000,000.00

Issued Shares

Type of Security / Stock Symbol	Before Capital Restructuring (current)	Decrease in ACS	Increase in ACS	After Capital Restructuring
Common stock/MED	700,000,000	none	2,459,292,441	3,159,292,441

Outstanding Shares

Type of Security / Stock Symbol	Before Capital Restructuring (current)	Decrease in ACS	Increase in ACS	After Capital Restructuring
Common stock/MED	700,000,000	none	2,459,292,441	3,159,292,441

Listed Shares

Type of Security / Stock Symbol	Before Capital Restructuring (current)	Decrease in ACS	Increase in ACS	After Capital Restructuring
Common stock/MED	700,000,000	none	2,459,292,441	3,159,292,441

Treasury Shares

Type of Security / Stock Symbol	Before Capital Restructuring (current)	Decrease in ACS	Increase in ACS	After Capital Restructuring
Common stock/MED	none	none	none	none

Par Value

Type of Security / Stock Symbol	Before Capital Restructuring (current)	Decrease in ACS	Increase in ACS	After Capital Restructuring
Common stock/MED	Php1.00	Php0.95	-	Php0.05

Movement in the total stockholders' equity account

ACS

Type of Security /Stock Symbol	Beginning Balance	Entries to record the decrease in ACS		Balance after decrease in ACS	Entries to record the increase in ACS		Balance after increase in ACS
		Dr	Cr		Dr	Cr
Common stock/MED	Php700,000,000	Php665,000,000	-	Php35,000,000	-	Php435,000,000	Php470,000,000

Issued and Outstanding Shares

Type of Security /Stock Symbol	Beginning Balance	Entries to record the decrease in ACS		Balance after decrease in ACS	Entries to record the increase in ACS		Balance after increase in ACS
		Dr	Cr		Dr	Cr
Common stock/MED	700,000,000	-	-	700,000,000	-	2,459,292,441	3,159,292,441

Treasury Shares

Type of Security /Stock Symbol	Beginning Balance	Entries to record the decrease in ACS		Balance after decrease in ACS	Entries to record the increase in ACS		Balance after increase in ACS
		Dr	Cr		Dr	Cr
Common Stock/MED	-	-	-	-	-	-	-

Additional Paid-In Capital

Beginning Balance	Entries to record the decrease in ACS		Balance after decrease in ACS	Entries to record the increase in ACS		Balance after increase in ACS
	Dr	Cr		Dr	Cr
Php25,498,912	-	Php665,000,000	Php690,498,912	-	-	Php690,498,912

Deficit

Beginning Balance	Entries to record the decrease in ACS		Balance after decrease in ACS	Entries to record the increase in ACS		Balance after increase in ACS
	Dr	Cr		Dr	Cr
(Php806,294,123)	-	Php665,000,000	(Php141,294,123)	-	-	(Php141,294,123)

Total Stockholders' Equity

Beginning Balance	Entries to record the decrease in ACS		Balance after decrease in ACS	Entries to record the increase in ACS		Balance after increase in ACS
	Dr	Cr		Dr	Cr
(Php82,426,374)	-	-	(Php82,426,374)	-	Php122,964,622	Php40,538,248

Proposed timetable of the quasi-reorganization that includes the following

Expected date of filing the amendments to the Articles of Incorporation with the SEC	Dec 1, 2017
Expected date of SEC approval of the Amended Articles of Incorporation	Feb 2, 2018

Procedure(s) for updating stock certificates

Details of Stock Transfer Agent

Name	Professional Stock Transfer, Inc.
Address	10/F, Telecom Plaza, 316 Sen. Gil Puyat Ave., Makati City
Contact Person	Jenny C. Serafica

Inclusive dates when the old stock certificates can be replaced

Start Date	TBA
End Date	TBA

Documentary requirements

Individual Shareholders
TBA
Corporate Shareholders
TBA

Date of availability of new stock certificates	TBA

Procedures in case of lost stock certificates
TBA
Other Relevant Information
Please note that this disclosure pertains to a capital restructuring in connection with MED's recapitalization plan. The report is hereby amended to reflect that the shareholders representing at least 2/3 of the outstanding capital stock of the Corporation approved the actions pertaining to the equity restructuring during the annual stockholders' meeting held on 24 November 2017. These actions shall further be subject to SEC approval. The expected date of filing the amendments to the Articles of Incorporation with the SEC as well as the expected date of SEC approval of the amended Articles of Incorporation was also indicated in this report.